Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of gynecologic oncology and American society of clinical oncology clinical practice guideline

Alexi A. Wright, Kari Bohlke, Deborah K. Armstrong, Michael A. Bookman, William A. Cliby, Robert L. Coleman, Don S. Dizon, Joseph J. Kash, Larissa A. Meyer, Kathleen N. Moore, Alexander B. Olawaiye, Jessica Oldham, Ritu Salani, Dee Sparacio, William P. Tew, Ignace Vergote, Mitchell I. Edelson

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)717-718
Number of pages2
JournalObstetrical and Gynecological Survey
Volume71
Issue number12
DOIs
StatePublished - Dec 1 2016

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Wright, A. A., Bohlke, K., Armstrong, D. K., Bookman, M. A., Cliby, W. A., Coleman, R. L., Dizon, D. S., Kash, J. J., Meyer, L. A., Moore, K. N., Olawaiye, A. B., Oldham, J., Salani, R., Sparacio, D., Tew, W. P., Vergote, I., & Edelson, M. I. (2016). Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of gynecologic oncology and American society of clinical oncology clinical practice guideline. Obstetrical and Gynecological Survey, 71(12), 717-718. https://doi.org/10.1097/01.ogx.0000508241.20157.7e